We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M Turnover 4.26%
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$98.4M
AUM Growth
-$1.48M
Cap. Flow
-$9.24M
Cap. Flow %
-9.4%
Top 10 Hldgs %
38.7%
Holding
69
New
4
Increased
5
Reduced
48
Closed
4
Avg Time Held
2.8 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.3 years

Top Buys

Rank Stock Value
1
CY
Cypress Semiconductor
CY
+$2.49M
2
IIN
IntriCon Corporation
IIN
+$293K
3
ACN icon
Accenture
ACN
+$214K
4
BLFS icon
BioLife Solutions
BLFS
+$160K
5
TLGT
Teligent, Inc
TLGT
+$69.1K

Top Sells

Rank Stock Value
1
OCLR
Oclaro Inc.
OCLR
+$4.34M
2
QRVO icon
Qorvo
QRVO
+$1.78M
3
CALD
Callidus Software, Inc.
CALD
+$1.38M
4
FNSR
Finisar Corp
FNSR
+$1.06M
5
ARRY icon
Array Biopharma Inc
ARRY
+$658K

Sector Composition

Rank Sector Weight
1 Healthcare 45.77%
2 Technology 34.24%
3 Industrials 5.22%
4 Financials 3.79%
5 Miscellaneous 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XENT
1
DELISTED
Intersect ENT, Inc
XENT
$7.73M 7.86%
196,776
-5,167
-3% -$189K
2015 Q1
12 quarters
SRGA
2
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4.05M 4.12%
29,377
-816
-3% -$111K
2013 Q2
19 quarters
PODD icon
3
Insulet
PODD
$9.62B
$3.57M 3.63%
41,151
-1,463
-3% -$114K
2014 Q2
15 quarters
LGND icon
4
Ligand Pharmaceuticals
LGND
$5.95B
$3.54M 3.59%
34,312
-996
-3% -$98.5K
2013 Q2
19 quarters
CALD
5
DELISTED
Callidus Software, Inc.
CALD
$3.38M 3.44%
94,160
-40,495
-30% -$1.38M
2016 Q1
8 quarters
IDTI
6
DELISTED
Integrated Device Technology I
IDTI
$3.29M 3.35%
107,710
-2,808
-3% -$87.2K
2013 Q2
19 quarters
TLGT
7
DELISTED
Teligent, Inc
TLGT
$3.29M 3.34%
97,824
+2,171
+2% +$69.1K
2014 Q1
16 quarters
NEO icon
8
NeoGenomics
NEO
$2.22B
$3.24M 3.3%
397,477
-8,967
-2% -$72.6K
2013 Q2
19 quarters
OCLR
9
DELISTED
Oclaro Inc.
OCLR
$3.05M 3.1%
318,895
-578,105
-64% -$4.34M
2013 Q2
19 quarters
OMCL icon
10
Omnicell
OMCL
$1.64B
$2.92M 2.97%
67,320
-1,521
-2% -$69.9K
2013 Q2
19 quarters
CVLT icon
11
Commault Systems
CVLT
$6.59B
$2.9M 2.95%
50,660
-1,897
-4% -$102K
2014 Q2
15 quarters
EGHT icon
12
8x8 Inc
EGHT
$299M
$2.64M 2.68%
141,507
-3,843
-3% -$68K
2016 Q2
7 quarters
ATRC icon
13
AtriCure
ATRC
$2.94B
$2.6M 2.65%
126,846
-589
-0.5% -$10.6K
2013 Q2
19 quarters
TWLO icon
14
Twilio
TWLO
$42B
$2.59M 2.64%
67,885
-592
-0.9% -$18.7K
2017 Q4
1 quarter
VCEL icon
15
Vericel Corp
VCEL
$2.1B
$2.58M 2.62%
259,227
-33,843
-12% -$280K
2017 Q1
4 quarters
MXL icon
16
MaxLinear
MXL
$7.09B
$2.57M 2.61%
112,912
-1,440
-1% -$35.8K
2014 Q3
14 quarters
CY
17
DELISTED
Cypress Semiconductor
CY
$2.47M 2.51%
+145,531
New +$2.49M
2018 Q1
0 quarters
SWKS icon
18
Skyworks Solutions
SWKS
$18.6B
$2.43M 2.47%
24,237
-1,116
-4% -$116K
2013 Q2
19 quarters
NXTM
19
DELISTED
NxStage Medical Inc.
NXTM
$2.33M 2.37%
93,888
-4,780
-5% -$116K
2013 Q4
17 quarters
CYBR icon
20
DELISTED
CyberArk
CYBR
$2.15M 2.18%
42,035
+341
+0.8% +$15.9K
2016 Q4
5 quarters
GTLS icon
21
DELISTED
Chart Industries
GTLS
$2.04M 2.08%
34,651
-1,226
-3% -$65.9K
2017 Q3
2 quarters
IMPV
22
DELISTED
Imperva, Inc.
IMPV
$2.03M 2.07%
46,961
-676
-1% -$30.4K
2016 Q4
5 quarters
FNSR
23
DELISTED
Finisar Corp
FNSR
$1.92M 1.95%
121,508
-56,088
-32% -$1.06M
2013 Q2
19 quarters
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.3B
$1.69M 1.72%
36,976
-7,145
-16% -$298K
2016 Q2
7 quarters
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.44M 1.46%
101,027
-4,099
-4% -$60.6K
2017 Q2
3 quarters
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Kopp Investment Advisors held 69 positions worth $98.4M, down 1.5% from $99.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Kopp Investment Advisors withdrew a net $9.24M in Q1 2018, closing 4 positions and reducing 48 holdings. Its most notable exit was Qorvo, an estimated $1.78M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

Against the trend, Kopp Investment Advisors opened a new position in Cypress Semiconductor worth $2.47M.

  • Kopp Investment Advisors's largest Q1 2018 buy was Cypress Semiconductor: 145,531 shares worth $2.47M.
  • Kopp Investment Advisors added most to Teligent, Inc in Q1 2018, an estimated $69.1K increase.
  • Kopp Investment Advisors's biggest Q1 2018 reduction was Oclaro Inc., cutting an estimated $4.34M.
  • Kopp Investment Advisors fully exited Qorvo in Q1 2018, selling an estimated $1.78M.
  • Kopp Investment Advisors's ten largest holdings make up 39% of its $98.4M portfolio in Q1 2018.
  • Kopp Investment Advisors opened 4 new positions and closed 4 in Q1 2018.
  • Kopp Investment Advisors's portfolio value fell 1.5% quarter-over-quarter to $98.4M.

Based on Kopp Investment Advisors's 13F filing for Q1 2018, filed 14 May 2018.